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ABSTRACT
Background. Multi-parametric magnetic resonance imaging
(MRI) provides the potential for a more comprehensive non-
invasive assessment of organ structure and function than indi-
vidual MRI measures, but has not previously been comprehen-
sively evaluated in chronic kidney disease (CKD).
Methods. We performed multi-parametric renal MRI in per-
sons with CKD (n¼ 22, 616 24 years) who had a renal biopsy
and measured glomerular ﬁltration rate (mGFR), and matched
healthy volunteers (HV) (n¼ 22, 616 25 years). Longitudinal
relaxation time (T1), diffusion-weighted imaging, renal blood
ﬂow (phase contrast MRI), cortical perfusion (arterial spin la-
belling) and blood-oxygen-level-dependent relaxation rate
(R2*) were evaluated.
Results.MRI evidenced excellent reproducibility in CKD (coef-
ﬁcient of variation<10%). Signiﬁcant differences between CKD
and HVs included cortical and corticomedullary difference
(CMD) in T1, cortical and medullary apparent diffusion coefﬁ-
cient (ADC), renal artery blood ﬂow and cortical perfusion.
MRI measures correlated with kidney function in a combined
CKD and HV analysis: estimated GFR correlated with cortical
T1 (r ¼ 0.68), T1 CMD (r ¼ 0.62), cortical (r¼ 0.54) and
medullary ADC (r¼ 0.49), renal artery ﬂow (r¼ 0.78) and cor-
tical perfusion (r¼ 0.81); log urine protein to creatinine ratio
(UPCR) correlated with cortical T1 (r¼ 0.61), T1 CMD
(r¼ 0.61), cortical (r ¼ 0.45) and medullary ADC (r ¼
0.49), renal artery ﬂow (r ¼ 0.72) and cortical perfusion (r
¼ 0.58). MRI measures (cortical T1 and ADC, T1 and ADC
CMD, cortical perfusion) differed between low/high interstitial
ﬁbrosis groups at 30–40% ﬁbrosis threshold.
Conclusion. Comprehensive multi-parametric MRI is repro-
ducible and correlates well with available measures of renal func-
tion and pathology. Larger longitudinal studies are warranted to
evaluate its potential to stratify prognosis and response to ther-
apy in CKD.
Keywords: chronic kidney disease, haemodynamics, magnetic
resonance imaging, multi-parametric, renal function
INTRODUCTION
Chronic kidney disease (CKD) is a major global health burden
[1] affecting 13% of adults [2], with rates predicted to rise by 5–
8% per annum [3]. CKD encompasses a range of aetiologies but
progresses by a combination of common pathological mecha-
nisms including glomerular capillary hypertension and hyper-
filtration, inflammation, vascular rarefaction, hypoxia and
fibrosis [4, 5]. Advanced magnetic resonance imaging (MRI)
techniques offer the potential to assess and quantify pathophys-
iological processes in the kidneys non-invasively (as opposed to
renal biopsy) and without the use of gadolinium contrast
agents. However, MRI techniques are underutilized in nephrol-
ogy, in part as they have been applied in isolation. Conceptually,
a more comprehensive assessment of renal structure, micro-
structure, haemodynamics and oxygenation is provided by
multi-parametric MRI. The value of multi-parametric MRI has
been described in cancer [6, 7], for example, in guiding prostate
biopsies, where it has helped to reduce the biopsy rate [8, 9], and
in animal models of CKD [10]. To date, multi-parametric MRI
has not been applied to patients with CKD.
Here, we assess the use of multi-parametric MRI in persons
with CKD and healthy volunteers (HVs), acquiring diffusion
weighted imaging (DWI) [11] and T1 [12] (spin-lattice relaxa-
tion time) mapping measures to study renal microstructure,
phase contrast MRI (PC-MRI) and Arterial Spin Labelling
(ASL) [13] to study renal haemodynamics and blood-oxygen-
level-dependent (BOLD) [14] transverse relaxation rate (R2*) to
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assess renal tissue oxygenation [15]. We report the reproduc-
ibility of each MRI measure, and compare MRI measures with
biochemical measures of kidney function and histopathology.
MATERIALS AND METHODS
Participants
Over a 12 month period, persons with CKD Category G3–4
[estimated glomerular filtration rate (eGFR) 15–59 mL/min/
1.73 m2] aged 18 years who had undergone renal biopsy as
part of clinical care within the previous 90 days were recruited.
The decision to perform a kidney biopsy was based on individu-
alized clinical decision-making by a senior nephrologist; our
centre performs 130 native renal biopsies per annum.
Exclusion criteria were contraindications to MRI, an episode of
acute kidney injury within the preceding 3 months, renal trans-
plant recipients, known iodine allergy, pregnancy and inability
to provide fully informed consent. A HV group (eGFR>60
mL/min/1.73 m2 and no proteinuria) who matched 1:1 to each
CKD patient for age (65 years) and gender was recruited.
The study was approved by the East Midlands Research
Ethics committee and registered at ClinicalTrials.gov
(Identifier: NCT03578523). All participants gave written in-
formed consent.
Clinical assessment
Demographic data, medical history and anthropomorphic
measurements were collected at study entry. This included
blood pressure, eGFR from serum creatinine concentration us-
ing the Chronic Kidney Disease Epidemiology Collaboration
(CKD-EPI) formula [16] and urine protein to creatinine ratio
(UPCR) measured from a single early morning urine sample.
In the CKD group only, measured GFR (mGFR) was
assessed using iohexol clearance. A total of 5mL of iohexol
(Omnipaque240) was administered intravenously. Blood was
sampled at 120, 180 and 240min in patients with eGFR>40
mL/min/1.73 m2, with a further sample at 360min in patients
with eGFR<40 mL/min/1.73 m2. Samples were centrifuged
and serum frozen at 80C until single batch analysis. Iohexol
clearance was calculated from the rate of decline in iohexol con-
centration corrected for body surface area (BSA), measured us-
ing reverse-phase high performance liquid chromatography
(Chemical Pathology Laboratory, John Radcliffe Hospital,
Oxford, UK).
Multi-parametric renal MRI
The multi-parametric renal MRI scan protocol follows that
described in Cox et al. [17]. This was performed in the CKD
group within 7 days of biochemical measures, and again after
7–14 days to assess repeatability. HVs had a single scan.
Scanning was performed on a 3T Philips Ingenia scanner
(Multi-Transmit, d-Stream). Balanced turbo field echo (bTFE)
localizer scans were acquired in three orthogonal planes to
quantify kidney volume and plan placement of the five contigu-
ous coronal oblique slices collected for multi-parametric MRI
(288 mm 288 mm field-of-view with 3 mm 3 mm in-plane
resolution, 5mm slice thickness). Data were acquired at end-
expiration.
T1 mapping. A respiratory-triggered inversion recovery (IR)
sequence [inversion times (TIs): 200/300/400/500/600/700/
800/900/1000/1100/1200/1300/1500ms, temporal slice spacing
58ms] with fat-suppressed spin-echo EPI (SE-EPI) readout
(SENSE 2.3/TE 27ms) was collected. In addition, a 1.5 mm 
1.5 mm 5 mm IR balanced fast field echo (IR-bFFE) T1 data-
set was acquired at the same TIs (temporal slice spacing
450ms) in both ascend and descend slice order.
DWI. Respiratory-triggered fat-suppressed SE-EPI DWI
data (SENSE 2.3/TE 67ms) was acquired at 11 b-values (0/5/
10/20/30/50/100/200/300/400/500 s/mm2) in three orthogonal
directions to reduce the influence of diffusion anisotropy. A
maximum b-value of 500 s/mm2 was chosen due to the limita-
tion of the 3T Ingenia gradients in reaching a higher b-value
while maintaining an acceptable echo time.
ASL perfusion. Respiratory-triggered Flow Alternating
Inversion Recovery ASL data were acquired with in-plane pre-
and post-saturation pulses, a post-label delay (PLD) of 1800ms
and selective (S)/non-selective (NS) thickness of 45/400mm,
with 25 S/NS pairs. Data were collected with a SE-EPI readout
(SENSE 2.3/TE 27ms). An inflow scan (4 S/NS pairs at PLDs
300/500/700/900ms) and M0 scan were acquired for
quantification.
Renal artery blood flow. A non-contrast enhanced MR an-
giogram was acquired to plan PC-MRI slice placement prior to
bifurcations of the renal artery. PC-MRI data were collected on
each renal artery in a breath hold [flip-angle 25, resolution 1.2
mm  1.2 mm  6 mm, 20 phases, velocity encoding (vENC)
100 cm/s].
BOLD data. BOLD R2* data were acquired using a multi-
echo fast-field-echo (mFFE) scheme (12 echoes, TE/DTE 5/
3ms, SENSE 2, 25 flip angle, three breath-holds).
Data analysis
Multi-parametric renal MRI. Total kidney volume. Kidney
volume was computed by manually tracing the kidney on the
coronal bTFE localizer images (Analyze9VR , AnalyzeDirect,
Overland Park, KS, USA).
Renal artery blood flow and global perfusion. Renal artery blood
flow was assessed using Q-flow software (Philips Medical
Systems, Best, The Netherlands). Mean flow velocity (cm/s),
cross-sectional area of the lumen (mm2) and bulk renal blood
flow (mL/s) over the cardiac cycle were calculated for each renal
artery and summed to determine total renal artery flow (mL/
min). Global perfusion was calculated for each kidney by cor-
recting renal artery blood flow for total kidney volume, and av-
eraged across kidneys.
Multi-parametric maps were computed using in-house soft-
ware (MATLAB, TheMathworks Inc., Natick, MA, USA).
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T1 mapping. SE-EPI/bFFE IR data were fit to generateT1/apparent
T1 (T1*) andM0maps.
DWI mapping. Apparent diffusion coefficient (ADC)maps were
generated from fitting the log of the exponential signal decay to
all b-values. True diffusion (D), pseudo-diffusion (D*) and perfu-
sion fraction (f) were fit from the intravoxel incoherent motion
(IVIM) model. D was fit from b-values>200 s/mm2, f was deter-
mined from the zero intercept of this fit, and D* from a mono-
exponential fit using the pre-calculated values ofD and f [18].
ASL perfusion mapping. Perfusion-weighted images were com-
puted, realigned and averaged to create a single perfusion-
weighted (DM) map. DM, inflow,M0 and T1 maps were used in
a kinetic model to calculate tissue perfusion maps [17].
R2* mapping. mFFE data were fit to form R2* maps from the
log of the exponential signal decay.
Renal cortex and medulla definition and multi-parametric MRI estima-
tion. A histogram of T1 values within both kidneys was used
to define a T1 threshold to segment renal cortex and medulla
masks. These masks were applied to each multi-parametric
map generating a histogram of each MRI measure for cortex
and medulla [17] to which a Gaussian curve was fit, and the
mode and full-width-at-half-maximum computed. In addition,
the corticomedullary difference (CMD) in each multi-paramet-
ric measure was computed.
Renal biopsy analysis. Renal biopsy tissue underwent stan-
dard histopathological processing. In addition, tissue blocks
were stained with Picro-Sirius Red Solution (Sigma-Aldrich,
Direct Red 80) for Collagens I and III. Sirius red slides were
uploaded to Slidepath and analysed offline using Tissue Studio
4.0 software (Definiens, Munich, Germany), a dedicated soft-
ware package for quantitative digital pathology. A region-of-
interest (ROI) of cortical tissue in each slide was drawn to ex-
clude non-interstitial structures (medulla, capsule, fat, glomer-
uli and arterioles). Following this, the Tissue Studio 4.0
software automatically quantified the percentage of red staining
(collagen) as a measure of cortical interstitial fibrosis (IF).
Statistical analysis
Analysis was performed using SPSS version 21 (IBMVC ) and
graphs generated using Prism 6 (GraphPad Software, Inc., La
Jolla, CA, USA). A Shapiro–Wilk normality test was applied to
each MRI measure. Normal data are expressed as mean 6 SD
and non-normal as median (interquartile range, IQR). Since no
significant difference in multi-parametric measures was ob-
served between right and left kidneys (paired t-test) the mean of
both kidneys was used in analyses, except for comparisons with
histological measures, whenMRI measures of the left (biopsied)
kidney were used. Differences between CKD and HV groups
were assessed using a paired t-test with Bonferroni correction
for multiple comparisons; P< 0.05 was considered statistically
significant. Between session repeatability of MRI measures in
CKDwas assessed from the intra-subject coefficient of variation
(CoV) and intraclass correlation coefficient (ICC). A Pearson
or Spearman correlation coefficient (normality test dependent)
assessed the relationship between MRI and biochemical meas-
ures [eGFR and log(UPCR)] across both CKD and HV subjects,
and for the CKD group alone. We performed a multivariable
linear regression analysis in SPSS to determine the association
between MRI data and biochemical measures [eGFR and
log(UPCR)]. This used the stepwise selection of two MRI cova-
riables that were biologically plausible, but not measures that
yield the same resultant quantifiable measure (i.e. ASL perfu-
sion and renal artery blood flow).
To explore the association of MRI measures with degree of
IF in CKD, a range of thresholds of Sirius red fibrosis scores
(20–70% in 10% increments) for defining ‘Low’ and ‘High’ IF
was tested [19]. ‘High’ and ‘Low’ IF values of eachMRI parame-
ter were then computed, and a mixed factorial analysis of vari-
ance (ANOVA) was performed using each IF cut-off threshold
as the within-subject factor, and fibrosis level (‘High’, ‘Low’) as
the between-subject factor.
RESULTS
A total of 44 participants were recruited, 22 CKD patients and
age-matched HVs. Baseline characteristics are shown in Table 1
and GFR data in Figure 1A. As expected, eGFR and mGFR
were highly correlated (R¼ 0.83, P< 0.001). In both HV and
CKD groups, eGFR fell with age (Figure 1B). In CKD, the pri-
mary aetiology was ischaemic (n¼ 8), interstitial (n¼ 3) and
glomerular (n¼ 11) pathology; no patients had diabetic kidney
disease. The median time from biopsy to first MRI scan was 62
(IQR 64) days.
Repeatability of MRI parameters in the CKD group
Table 2 provides eachMRI measure for the CKD group with
the associated CoV and ICC from repeatability data. CoVs were
lowest for cortical and medullary T1 [both SE-EPI and bFFE
readout (<4%)], cortical and medullary R2* (<7%), cortical
ADC (<6%) and total kidney volume (<4%). ICCs were>0.75
for cortical T1, cortical ADC, renal artery blood flow, volume
and cortical and medullary R2*.
Differences in MRI parameters between the CKD and
HV group
Significant differences in MRI parameters were observed be-
tween the CKD and HV group (Figure 2).
Renal macro- and microstructure. Kidney volume was sig-
nificantly lower in the CKD group compared with HVs (CKD:
3226 114 mL, HV: 3966 99 mL; P¼ 0.02) as well as kidney
volume corrected for BSA [CKD: 165 (39)mL/m2, HV:
1946 28 mL/m2; P¼ 0.009]. These data are shown graphically
in Supplementary data, Figure S1.
Cortical SE-EPI T1 was significantly longer in the CKD
group compared with HVs (CKD: 15746 74 ms, HV:
14326 87 ms; P< 0.001, Figure 2A), but no significant differ-
ence was evident in medullary T1 (CKD: 17546 50 ms, HV:
17316 134 ms; P¼ 0.29). Both CKD and HV groups had a sig-
nificantly longer medullary T1 than cortex (P< 0.0001).
Increased cortical T1 in the CKD group resulted in a signifi-
cantly reduced T1 CMD (DT1) in the CKD group compared
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D
ow
nloaded from
 https://academ
ic.oup.com
/ndt/advance-article-abstract/doi/10.1093/ndt/gfz129/5525254 by U
niversity of N
ottingham
 user on 17 July 2019
with HVs (CKD: 1836 44 ms, HV: 2986 98 ms;
P¼ 0.001). This finding was replicated in T1 bFFE data (DT1
CKD: 2016 71 ms, DT1 HV: 3276 77 ms; P< 0.001),
which showed a strong correlation between T1 SE-EPI and
bFFE measures, Supplementary data, Figure S2A. It was also
noted that both HV and CKD groups showed a trend for in-
creased cortical T1 with age (CKD: R¼ 0.42, P¼ 0.07, HV:
R¼ 0.42, P¼ 0.06).
ADC was lower in the CKD group compared with HVs in
both cortex [CKD: 1.94 (0.44)  103 mm2/s, HV: 2.36 0.1 
103 mm2/s; P¼ 0.030] and medulla (CKD: 2.036 0.22 
103 mm2/s, HV: 2.26 0.1  103 mm2/s; P¼ 0.031;
Figure 2B). ADC was significantly higher in the cortex than me-
dulla in the HV group resulting in a positive ADC CMD
(DADC) (P< 0.01); no significant CMD was found in the CKD
group. Similar trends were found for true diffusion (D)
(Supplementary data, Figure S2).
Renal oxygenation. There was no significant difference in
cortical or medullary R2* between CKD and HV groups. Cortical
R2* was significantly (P< 0.001) lower than medullary R2* in
both CKD (cortex: 20.46 3.2/s, medulla: 32.66 8.0/s) and HV
(cortex: 18.66 2.2/s, medulla: 31.06 6.1/s) groups.
Renal haemodynamics. Cortical perfusion assessed using
ASL was significantly lower in the CKD group than the HV
group [CKD: 71 (49)mL/100 g/min, HV: 2006 56 mL/100 g/
min; P< 0.001], as was total renal artery blood flow [CKD: 486
(174)mL/min, HV: 8566 160 mL/min; P¼ 0.02] and global
kidney perfusion [CKD: 132 (108)mL/100 g/min, HV: 2256 75
mL/100 g/min; P¼ 0.0078].
Association between MRI data and biochemical
measures
Figure 3 shows the correlation matrix of the univariate anal-
yses of multi-parametric MRI and biochemical measures [eGFR
and log(UPCR)] for the combined CKD and HV groups, with
graphs of significant correlations shown in Figure 4. Cortical T1
correlated strongly with eGFR and log(UPCR), as did T1 CMD,
cortical ADC and to a lesser extent medullary ADC. ADC
CMD did not correlate with either eGFR or log(UPCR). Kidney
volume was positively correlated with eGFR, with a stronger
correlation after BSA correction. Haemodynamic measures of
cortical perfusion, total renal artery flow and global perfusion
all correlated strongly with eGFR and log(UPCR). There were
no significant correlations between R2* and any biochemical
measures. Significant correlations were observed between some
but not all MRI measures. As expected, there were significant
correlations between haemodynamic measures (cortical perfu-
sion, total renal artery flow and global perfusion), and for indi-
vidual MRI parameters between cortical and medullary
measures. In addition, cortical T1 correlated with perfusion, to-
tal renal artery blood flow and global perfusion; T1 CMD corre-
lated with perfusion and total renal artery blood flow; and
cortical ADC with perfusion.
Using multivariable linear regression, the best predictive
model of eGFR fromMRI measures included cortical perfusion
and cortical T1 [eGFR¼ 143 – 0.77  (cortical T1) þ 0.27 
(cortical perfusion); R¼ 0.87, P< 0.001]. Cortical perfusion
and cortical T1 resulted in a weaker association to predict
log(UPCR) [log(UPCR)¼2.8þ 0.03 (cortical T1)0.03
(cortical perfusion); R¼ 0.58, P¼ 0.001]. A significant
FIGURE 1: GFR. (A) eGFR in the HV group; eGFR and mGFR in the CKD group. (B) Correlation of eGFR with age, showing a signiﬁcant cor-
relation for both the HV (open circles) (R ¼ 0.62, P¼ 0.002) and CKD (ﬁlled circles) (R ¼ 0.63, P¼ 0.002) group.
Table 1. Baseline characteristics of the CKD and HV groups
Baseline demographics CKD HV
(n¼ 22) (n¼ 22)
Ethnicity (no. Caucasian) 18 (81%) 19 (86%)
Gender (no. male) 17 (77%) 17 (77%)
Age (years) 616 24 616 25
Height (m) 1746 8 1766 9
Weight (kg) 866 12 826 13
BMI (kg/m2) 296 4 26.56 3
Baseline serum creatinine (mmol/L) 1596 51 776 11
Baseline eGFR (mL/min/1.73 m2) 396 14 926 12
Baseline mGFR (mL/min/1.73 m2) 346 23
UPCR (mg/mmol) 72 (IQR 108) 6 (IQR 9)
Systolic blood pressure (mmHg) 1366 22 1306 16
Diastolic blood pressure (mmHg) 856 16 796 13
Primary renal disease category, n (%)
Glomerular disease 11 (50)
Tubulointerstitial disease 3 (14)
Ischaemic nephropathy 8 (36)
Diabetes mellitus, n (%) 6 (27) 1 (5)
Hypertension, n (%) 15 (68) 5 (23)
Number on RAAS blockade, n (%) 13 (59) 3 (14)
BMI, body mass index; RAAS, renin–angiotensin–aldosterone system.
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Table 2. Multi-parametric MRI measures in CKD patients [shown as mean 6 SD or median (IQR) dependent on normality] and assessment of their
repeatability as deﬁned by the intra-subject CoV and ICC
Mean6 SD or CoV (%) ICC
median (IQR)
Cortical T1 SE-EPI (ms) 15746 74 2.9 0.76
Medullary T1 SE-EPI (ms) 17546 50 3.9 0.47
Cortical T1 bFFE (ms) 14036 76 2.4 0.91
Medullary T1 bFFE (ms) 16046 98 3.4 0.68
Cortical ADC (103 mm2/s) 2.0 (0.2) 5.3 0.69
Medullary ADC (103 mm2/s) 2.06 0.2 14 0.65
Cortical D (103 mm2/s) 1.76 0.2 7.7 0.49
Medullary D (103 mm2/s) 1.86 0.2 22 0.47
Cortical R2* (/s) 20.06 3.2 4.6 0.90
Medullary R2* (/s) 33.06 8.0 6.8 0.91
Cortical perfusion (mL/100 g/min) 71 (50) 23 0.67
Total renal artery ﬂow (mL/min) 490 (170) 18 0.86
Kidney volume corrected total renal artery ﬂow (mL/100 g/min) 130 (110) 18 0.76
Total kidney volume/BSA (mL/m2) 170 (39) 3.8 0.94
FIGURE 2: MRI parameters in the CKD and HV group for (A) SE-EPI T1 in cortex, medulla and CMD (DT1), (B) ADC in cortex, medulla
and CMD (DADC), (C) R2* in cortex, medulla and CMD (DR2*), (D) cortical perfusion as measured by ASL, total renal artery ﬂow and global
perfusion (estimated from correcting renal artery ﬂow for kidney volume). Signiﬁcant differences are seen between the CKD and HV group for
cortical T1 and DT1 (SE-EPI data shown here, with the correlation between SE-EPI and bFFE T1 measures shown in Supplementary data,
Figure S2), cortical and medullary ADC, cortical perfusion, cortical and medullary ADC, total renal artery ﬂow and global perfusion.
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association with log(UPCR) was also found for T1 CMD (DT1)
and cortical ADC [log(UPCR) ¼ 5.27þ 0.002  (DT1)  1.72
 (cortical ADC); R¼ 0.61, P¼ 0.005].
Figure 5A shows the correlation matrix of MRI measures
and biochemical measures [mGFR and log(UPCR)] for the
CKD group alone. There was a significant correlation of mGFR
with cortical perfusion and mGFR with total kidney volume
[Figure 5B, though this was not significant for BSA corrected
kidney volume (Figure 5A)]. Log(UPCR) had a negative corre-
lation with cortical and medullary ADC. Using multiple linear
regression, mGFR was predicted by combining cortical perfu-
sion and cortical T1 [mGFR ¼ 38.2þ 0.035 (cortical T1) þ
0.296  (cortical perfusion); R¼ 0.73, P¼ 0.03], or total BSA
corrected kidney volume and cortical perfusion
[mGFR¼ 4.65þ 0.064  (BSA corrected kidney volume) þ
0.290  (cortical perfusion); R¼ 0.76, P¼ 0.001]. Log(UPCR)
was not significantly associated with T1 CMD and cortical ADC
for the CKD group alone (R¼ 0.75, P¼ 0.08).
Association between MRI parameters and histological
measures
Histology of each individual in the CKD group is presented
in Supplementary data, Table S1. Figure 6 shows MRI parame-
ters for ‘Low’ and ‘High’ IF groups computed for fibrosis vary-
ing thresholds between 20% and 70% in 10% increments.
ANOVA revealed significant differences between ‘Low’ and
‘High’ IF groups for cortical T1, T1 CMD, cortical ADC, ADC
CMD and ASL cortical perfusion. Individual comparisons
showed significant differences between ‘Low’ and ‘High’ IF at
40% IF threshold for cortical T1, T1 CMD, cortical ADC and
ADC CMD, with additional significant differences in cortical
ADC at 50% and cortical perfusion at 30% IF thresholds.
DISCUSSION
MRI shows promise as a non-invasive technique for evaluating
whole kidney structure and function but progress towards clini-
cal application has been slow, in part because MRI measures
have generally been applied in isolation (e.g. DWI [20], BOLD
[15, 21–23] and ASL [24]). We show that multi-parametric
MRI can be conducted in a single scan session [25] with excel-
lent reproducibility in HVs and persons with CKD G3–4.
Several MRI parameters were able to distinguish CKD from
healthy kidneys, and correlated with measures of whole kidney
function (GFR and UPCR) as well as histopathological meas-
ures of IF.
The first aim of this study was to establish repeatability of
multi-parametric MRI measures in a CKD group before wider
application. We show individual MRI measures are highly re-
peatable, comparable to those previously reported in HVs by
our group [17]. Our description of how the individual MRI
measures are related is also important. Correlation of certain
MRI measures (e.g. ASL perfusion and renal artery blood flow,
Figure 3) confirms technical validity. Conversely, the observa-
tion that a number of MRI measures do not correlate confirms
MRI measures are sensitive to different structural or functional
alterations, supporting multi-parametric MRI.
We report significant differences in renal microstructure be-
tween the CKD and HV group assessed by T1 mapping and
DWI. Cortical T1 was increased in CKD, resulting in a signifi-
cantly reduced T1 CMD. Increased T1 reflects increased extra-
cellular fluid resulting from inflammation, interstitial oedema
or cellular swelling [18], or fibrosis due to the association of col-
lagen with supersaturated hydrogel [19, 26]. In tandem, the
CKD group had lower cortical ADC andD-values. Reduced dif-
fusion of water molecules may be due to fibrosis [19, 27], with
the accumulation of cells including fibroblasts in the interstitial
space during renal fibrogenesis and collagen deposition restrict-
ing water diffusion. Along with microstructural changes, we ob-
served a significant reduction in kidney volume in CKD
compared with HVs.
Haemodynamic assessment of the kidney included ASL per-
fusion mapping and PC-MRI renal artery blood flow, which
when corrected for kidney volume estimates global renal perfu-
sion (with the caveat that blood flow is equally distributed
across kidney volume, thus not accounting for lower perfusion
in the medulla or fibrotic tissue). Consistent with previous stud-
ies, total renal artery blood flow [28], cortical perfusion [24, 29–
31] and global perfusion were reduced in CKD compared with
HVs, likely reflecting vascular rarefaction in chronic fibrosis.
Our measures of cortical perfusion may appear lower than
other published values [24, 29–31], which may reflect a higher
proportion of ischaemic nephropathy in our cohort, or the
higher proportion of patients with lower GFR.
FIGURE 3: Correlation matrix for combined HV and CKD groups
of biochemical measures [eGFR and log(UPCR)] and multi-paramet-
ric MRI measures. Signiﬁcant correlations of MRI measures with
biochemical measures are shown in Figure 4. Between the multi-
parametric MRI measures, signiﬁcant correlations are observed be-
tween cortical T1 and cortical perfusion (R ¼ 0.595, P< 0.001), to-
tal renal artery blood ﬂow (R ¼ 0.655, P< 0.001), global perfusion
(R ¼ 0.435, P¼ 0.001); between T1 CMD (DT1) and cortical perfu-
sion (R ¼ 0.587, P< 0.001) and total renal artery blood ﬂow (R ¼
0.397, P¼ 0.05). Correlations are also seen between cortical ADC
and cortical perfusion (R¼ 0.452 P¼ 0.02). Between haemodynamic
measures, signiﬁcant correlations were observed between cortical
perfusion and total renal artery ﬂow (R¼ 0.596, P¼ 0.002), and cor-
tical perfusion and global perfusion (R¼ 0.44, P¼ 0.04).
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We observed nomeaningful differences in cortical or medul-
lary R2* values between CKD and HVs, noting our values show
good agreement with previous studies [23]. Current data re-
garding renal R2* data are conflicting; studies report both in-
creased cortical R2* in CKD compared with HVs attributed to
lower renal tissue oxygenation [32–34], and no difference [23].
Some of this variability may be explained in part by technical
factors (shimming method, ROI placement), although
Pruijm et al. [35] recently showed BOLD R2* correlates with a
faster decline in eGFR and a higher risk of adverse renal
outcomes.
As expected, MRI measures that differed significantly be-
tween CKD and HV groups strongly correlated with GFR (cor-
tical T1, cortical and medullary ADC, cortical perfusion,
FIGURE 4: MRI measures which show signiﬁcant correlations with eGFR and log(UPCR) across combined HV (open circles) and CKD (ﬁlled
circles) groups.
FIGURE 5: (A) Correlation matrix for the CKD group alone of biochemical measures [mGFR and log(UPCR)] and multi-parametric MRI
measures. (B)MRI measures which show signiﬁcant correlations with mGFR and log(UPCR) for the CKD group alone.
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BSA corrected kidney volume, renal artery flow and global per-
fusion). Within the CKD group (smaller range of renal function
and sample size), haemodynamic and structural measures (cor-
tical perfusion, cortical and medullary ADC, and kidney vol-
ume) correlated with mGFR. We also observed correlations
between MRI measures and proteinuria. Cortical T1 and T1
CMD had a strong positive correlation with log(UPCR), cou-
pled with a negative correlate of cortical and medullary ADC
with log(UPCR). ASL perfusion, renal artery blood flow and
global perfusion negatively correlated with log(UPCR). Mao et
al. [20] reported a negative correlation between diffusion meas-
ures and proteinuria and a positive correlation with eGFR.
There are few reports relating proteinuria and other MRI meas-
ures. An important observation is that MRI measures retained
independent associations with eGFR (cortical perfusion and
cortical T1) and proteinuria [T1 CMD (DT1) and cortical ADC],
supporting the use of multi-parametric MRI.
A number of previous MRI studies have attempted to non-
invasively measure renal fibrosis [36], with one or two MRI
measures being compared with subjective or objective measures
of IF from biopsy. Mao et al. [20] compared diffusion measures
with subjective assessment of renal fibrosis in CKD Stage G1–5
and showed a negative correlation between diffusion measures
and fibrosis score. In renal transplant recipients, Friedli et al.
[19] reported reduced ADC CMD to be the best predictor of
‘High’ IF defined to be>40% IF. Our results are broadly consis-
tent, with ADC and ADC CMD being significantly different be-
tween ‘Low’ and ‘High’ IF, and most apparent at 40% IF.
Additionally, we show T1 cortex, T1 CMD difference and ASL
cortical perfusion are predictors of IF. Our sample size renders
these results exploratory, but they support the potential of com-
bining multi-parametric MRI measures to improve prediction
of IF, clinically important as IF is one of the strongest predictors
of CKD progression.
FIGURE 6: Fibrosis percentage binned into a binary factor ‘Low’ (blue) or ‘High’ (orange) IF based on varying the ﬁbrosis threshold between
20% and 70%. It can be seen that changing the IF threshold results in a signiﬁcant difference between ‘Low’ and ‘High’ IF groups for cortical
T1 (P¼ 0.014) and T1 CMD (DT1) (P¼ 0.017), cortical ADC (P< 0.0001) and ADC CMD (DADC) (P¼ 0.048), and ASL-derived cortical per-
fusion (P¼ 0.001) as determined by ANOVA. Signiﬁcant differences (Wilcoxon P< 0.05) between ‘Low’ and ‘High’ IF groups for a given IF
threshold are shown by *.
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This study has limitations, with a relatively small sample size
and a range of disease types and age span, though the latter was
addressed by including a paired age-matched HV group.
In conclusion, multi-parametric MRI measures have good
reproducibility in CKD, can distinguish CKD from healthy kid-
neys, and correlate with biochemical and histopathological
measures. Further evaluation requires multicentre studies to as-
sess MRI measures across all CKD stages and in larger numbers
to identify the optimal combination ofMRImeasures, and longi-
tudinal studies to assess the prognostic value of multi-parametric
MRI compared with currently available biochemical measures.
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